Mumbai: Pharmaceutical company Ipca Laboratories on 25 May posted a 53.95% rise in net profit at Rs27.65 crore for the quarter ended 31 March 2007, against Rs17.96 crore for the same quarter last year.
Total income (net of excise) grew 27.4% to Rs221.53 crore for the fourth quarter ended 31 March, from Rs173.88 crore for the corresponding quarter a year ago, Ipca Laboratories informed the Bombay Stock Exchange.
The board of directors of the company at its meeting today declared a final dividend of Rs4 per share on shares of Rs10 each (40%) for the financial year 2006-07.
Together with the interim dividend of Rs 3.50 a share (35%) already declared and paid, the total dividend for the financial year amounts to Rs7.50 or 75%.
For the year ended 31 March 2007, the company posted a net profit (after exceptional items) of Rs122.23 crore, against Rs63.98 crore for the year-ago period.
The total income (net of excise) rose to Rs921.24 crore for the year ended 31 March, from Rs752.82 crore for the previous year.
The group posted a net profit of Rs126.17 crore for 2006-07, as compared to Rs1.50 crore for the period under consideration last year and total income (net of excise) increased to Rs939.11 crore from Rs759.54 crore.